Sandhya Nair
8 Papers
Sandhya Nair is an academic researcher. The author has contributed to research in topics: Internal medicine & Refractory (planetary science). The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
The GenomeAsia 100K Project enables genetic discoveries across Asia
Jeffrey D. Wall,Eric Stawiski,Aakrosh Ratan,Hie Lim Kim,Changhoon Kim,Ravi Gupta,Kushal Suryamohan,Elena S. Gusareva,Rikky W. Purbojati,Tushar Bhangale,Vadim Stepanov,Vladimir Kharkov,Markus S. Schröder,Vedam L. Ramprasad,Jennifer Tom,Steffen Durinck,Qixin Bei,Jiani Li,Joseph Guillory,Phalkek Sameer,Analabha Basu,Jeremy Stinson,Sandhya Nair,Sivasankar Malaichamy,Nidhan K. Biswas,John C. Chambers,Keith C. Cheng,Joyner T. George,Seik-Soon Khor,Jong Il Kim,Belong Cho,Ramesh Menon,Thiramsett Sattibabu,Akshi Bassi,Manjari Deshmukh,Anjali Verma,Vivek Gopalan,Jong-Yeon Shin,Mahesh Pratapneni,Sam Santhosh,Katsushi Tokunaga,Badrul Munir Md-Zain,Kok-Gan Chan,Madasamy Parani,Purushothaman Natarajan,Michael A. Hauser,R. Rand Allingham,Santiago-Turla,Arkasubhra Ghosh,Santosh Gopi Krishna Gadde,Christian Fuchsberger,Lukas Forer,Sebastian Schoenherr,Herawati Sudoyo,J. Stephen Lansing,Jonathan S. Friedlaender,George Koki,Murray P. Cox,Michael F. Hammer,Tatiana M. Karafet,Khai C. Ang,Syed Qasim Mehdi,Venkatesan Radha,Viswanathan Mohan,Partha P. Majumder,Somasekar Seshagiri,Jeong-Sun Seo,Stephan C. Schuster,Andrew S. Peterson +68 more
TL;DR: The pilot phase of the GenomeAsia 100K Project catalogues genetic variation, population structure and disease associations to facilitate genetic studies in Asian populations and increase representation in genetics studies worldwide.
Identification of African-Specific Admixture between Modern and Archaic Humans
Jeffrey D. Wall,Aakrosh Ratan,Eric Stawiski,Hie Lim Kim,Changhoon Kim,Ravi Gupta,Kushal Suryamohan,Elena S. Gusareva,Rikky W. Purbojati,Tushar Bhangale,Vadim Stepanov,Vladimir Kharkov,Markus S. Schrӧder,Vedam L. Ramprasad,Jennifer Tom,Steffen Durinck,Qixin Bei,Jiani Li,Joseph Guillory,Samir Phalke,Analabha Basu,Jeremy Stinson,Sandhya Nair,Sivasankar Malaichamy,Nidhan K. Biswas,John C. Chambers,Keith C. Cheng,Joyner T. George,Seik-Soon Khor,Jong Il Kim,Belong Cho,Ramesh Menon,Thiramsetti Sattibabu,Akshi Bassi,Manjari Deshmukh,Anjali Verma,Vivek Gopalan,Jong-Yeon Shin,Mahesh Pratapneni,Sam Santhosh,Katsushi Tokunaga,Badrul Munir Md-Zain,Kok-Gan Chan,Madasamy Parani,Purushothaman Natarajan,Michael A. Hauser,R. Rand Allingham,Cecilia Santiago-Turla,Arkasubhra Ghosh,Santosh Gopi Krishna Gadde,Christian Fuchsberger,Lukas Forer,Sebastian Shoenherr,Herawati Sudoyo,J. Stephen Lansing,Jonathan S. Friedlaender,George Koki,Murray P. Cox,Michael F. Hammer,Tatiana M. Karafet,Khai C. Ang,Syed Qasim Mehdi,Venkatesan Radha,Viswanathan Mohan,Partha P. Majumder,Sekar Seshagiri,Jeong-Sun Seo,Stephan C. Schuster,Andrew S. Peterson +68 more
TL;DR: This work searches for evidence of archaic admixture from a worldwide panel of 1,667 individuals using an approach that does not require the presence of an archaic human reference genome and finds evidence for at least one archaic admixtures event in sub-Saharan Africa.
19
P-240: Real-world assessment of treatment patterns and outcomes in patients with lenalidomide-refractory relapsed multiple myeloma from the SEER-Medicare database
Binod Dhakal,Hermann Einsele,Ravi Potluri,Jordan M. Schecter,William Deraedt,Nikoletta Lendvai,Ana R. Slaughter,Carolina Lonardi,Sandhya Nair,Jianming He,Jennifer Voelker,Patricia A. Cost,Satish Valluri,Fevzi Firat Yalniz,Lida Bubuteishvili Pacaud,Kwee Yong +15 more
2
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry Data.
Vladimir Maisnar,Ludek Pour,Ivan Spicka,Tomas Jelinek,Jiri Minarik,Alexandra Jungova,Martin Stork,Jan Straub,Jakub Radocha,Tomas Pika,Lenka Pospisilova,Sandhya Nair,P. Kunovszki,Roman Hájek +13 more
TL;DR: In this article , the authors reviewed data from the Czech Registry of Monoclonal Gammopathies, identified and characterized triple-class exposed (3CE) relapsed/refractory MM patients, treatment patterns after 3CE, assessed overall survival (OS), progression-free survival (PFS), time to next treatment (TTNT), explored cohorts with and without triple- and penta-refractoriness.
1